George A. Scangos, President and CEO at Vir Biotechnology, Inc. (VIR), sold 170,414 shares at $25.29 ($1.5M) on 2023-02-17, disclosed to the SEC on 2023-02-21.
Open-market sale of $1.5M VIR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 49,984 | $0 | 0.0% |
| 2 | $0.00 | 64,930 | $0 | 0.0% |
| 3 | $25.29 | 9,894 | $250K | 16.6% |
| 4 | $25.29 | 9,894 | $250K | 16.6% |
| 5 | $28.02 | 11,382 | $319K | 21.1% |
| 6 | $28.02 | 11,382 |
| $319K |
| 21.1% |
| 7 | $28.80 | 6,474 | $186K | 12.3% |
| 8 | $28.80 | 6,474 | $186K | 12.3% |
| Total | $8.87 avg | 170,414 | $1.5M | 100% |
| Filing → |
| VIR | SELL | 2024-02-26 | $614K | — | Filing → |
| VIR | SELL | 2024-02-20 | $568K | — | Filing → |
| VIR | SELL | 2023-02-24 | $1.4M | — | Filing → |